179 related articles for article (PubMed ID: 10095979)
1. The pharmacodynamics and efficacy of Implanon. An overview of the data.
Croxatto HB; Mäkäräinen L
Contraception; 1998 Dec; 58(6 Suppl):91S-97S. PubMed ID: 10095979
[TBL] [Abstract][Full Text] [Related]
2. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
Rossmanith WG; Steffens D; Schramm G
Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
[TBL] [Abstract][Full Text] [Related]
3. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant.
Mäkäräinen L; van Beek A; Tuomivaara L; Asplund B; Coelingh Bennink H
Fertil Steril; 1998 Apr; 69(4):714-21. PubMed ID: 9548163
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
Heikinheimo O; Gordon K; Williams RF; Hodgen GD
Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
[TBL] [Abstract][Full Text] [Related]
5. A randomized study of the effect of mifepristone alone or in conjunction with ethinyl estradiol on ovarian function in women using the etonogestrel-releasing subdermal implant, Implanon®.
Weisberg E; Croxatto HB; Findlay JK; Burger HG; Fraser IS
Contraception; 2011 Dec; 84(6):600-8. PubMed ID: 22078189
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics and pharmacodynamics of Implanon, a single-rod etonogestrel contraceptive implant.
Bennink HJ
Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():12-20. PubMed ID: 11246602
[TBL] [Abstract][Full Text] [Related]
7. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG
Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
[TBL] [Abstract][Full Text] [Related]
8. Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years.
Barbosa I; Coutinho E; Hirsch C; Ladipo O; Olsson SE; Ulmsten U
Fertil Steril; 1996 Apr; 65(4):724-9. PubMed ID: 8654629
[TBL] [Abstract][Full Text] [Related]
9. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
Xiao B; Zeng T; Wu S; Sun H; Xiao N
Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
[TBL] [Abstract][Full Text] [Related]
10. Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel.
Davies GC; Feng LX; Newton JR; Van Beek A; Coelingh-Bennink HJ
Contraception; 1993 Mar; 47(3):251-61. PubMed ID: 8462316
[TBL] [Abstract][Full Text] [Related]
11. Ovarian activity during regular oral contraceptive use.
Crosignani PG; Testa G; Vegetti W; Parazzini F
Contraception; 1996 Nov; 54(5):271-3. PubMed ID: 8934059
[TBL] [Abstract][Full Text] [Related]
12. Implant contraception.
Meckstroth KR; Darney PD
Semin Reprod Med; 2001 Dec; 19(4):339-54. PubMed ID: 11727176
[TBL] [Abstract][Full Text] [Related]
13. Temporal relationship between Uniplant insertion and changes in cervical mucus.
Barbosa IC; Coutinho E; Hirsch C; Ladipo OA; Olsson SE; Ulmsten U
Contraception; 1996 Oct; 54(4):213-7. PubMed ID: 8922874
[TBL] [Abstract][Full Text] [Related]
14. The effect of a synthetic progestogen, ethylnorgestrienone, on hypothalamic-pituitary-ovarian function, cervical mucus, vaginal cytology, and endometrial morphology.
Niaraki MA; Moghissi KS; Borin K
Fertil Steril; 1981 Mar; 35(3):284-8. PubMed ID: 6781938
[TBL] [Abstract][Full Text] [Related]
15. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
Zheng SR; Zheng HM; Qian SZ; Sang GW; Kaper RF
Contraception; 1999 Jul; 60(1):1-8. PubMed ID: 10549446
[TBL] [Abstract][Full Text] [Related]
16. Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition.
Mulders TM; Dieben TO
Fertil Steril; 2001 May; 75(5):865-70. PubMed ID: 11334895
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonographic features of the endometrium and the ovaries in women on etonogestrel implant.
Van den Bosch T; Donders GG; Riphagen I; Debois P; Ameye L; De Brabanter J; Van Huffel S; Van Schoubroeck D; Timmerman D
Ultrasound Obstet Gynecol; 2002 Oct; 20(4):377-80. PubMed ID: 12383321
[TBL] [Abstract][Full Text] [Related]
18. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
[TBL] [Abstract][Full Text] [Related]
19. Ultrasonographic and endocrine evaluation of ovarian function among Norplant implants users with regular menses.
Alvarez F; Brache V; Faundes A; Tejada AS; Thevenin F
Contraception; 1996 Nov; 54(5):275-9. PubMed ID: 8934060
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ovulation by an oral contraceptive containing 100 micrograms levonorgestrel in combination with 20 micrograms ethinylestradiol.
Spona J; Feichtinger W; Kindermann C; Wünsch C; Brill K
Contraception; 1996 Nov; 54(5):299-304. PubMed ID: 8934064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
